Brukinsa (zanubrutinib) is a brand-name prescription medication manufactured by BeiGene USA, Inc. It is FDA-approved to treat certain blood cancers that affect a type of white blood cell called B lymphocytes or B cells.
What is Brukinsa?
- Aug 11, 2023